Table 1.
Baseline characteristics of the participants in normotensive and hypertensive groups.
| Variables | Total (n = 312) | Normotensive (n = 181) | Hypertensive (n = 131) | p-value |
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | ||
| Gender, m/f | 225/87 | 130/51 | 95/36 | − |
| Age, year | 43.3 ± 12.6 | 40.4 ± 12.3 | 47.2 ± 12.0 | 0.000 |
| Height, cm | 162.1 ± 9.3 | 161.4 ± 9.3 | 160.8 ± 9.3 | 0.563 |
| Weight, kg | 65.2 ± 11.7 | 64 ± 10.3 | 66.9 ± 13.3 | 0.030 |
| BMI, kg/m2 | 25.2 ± 3.7 | 24.6 ± 3.7 | 26.0 ± 3.7 | 0.001 |
| WC, cm | 86.6 ± 10.4 | 84.8 ± 10 .0 | 88.9 ± 10.4 | 0.004 |
| HC, cm | 92.7 ± 8.7 | 90.9 ± 7.7 | 92.7 ± 8.7 | 0.110 |
| SBP, mmHg | 130.2 ± 17.9 | 119.5 ± 8.9 | 145 ± 16.5 | 0.000 |
| DBP, mmHg | 84.5 ± 10 .0 | 79.6 ± 7.2 | 91.3 ± 9.4 | 0.000 |
| FBG, mmol/dL | 7.3 ± 3.7 | 6.6 ± 3.2 | 8.0 ± 4.2 | 0.001 |
| SUA, mg/dL | 5.4 ± 1.8 | 5.2 ± 1.6 | 8.1 ± 4.2 | 0.004 |
| XO, U/L | 4.4 ± 2.8 | 4.0 ± 2.7 | 5.0 ± 2.7 | 0.002 |
| Creatinine, mg/dL | 0.9 ± 0.3 | 0.9 ± 0.3 | 0.8 ± 0.3 | 0.490 |
| TG, mg/dL | 199.7 ± 122.8 | 191 ± 112.4 | 210.8 ± 122.8 | 0.184 |
| TC, mg/dL | 217.7 ± 87.1 | 207.7 ± 80.7 | 230.6 ± 93.5 | 0.032 |
| HDL-C, mg/dL | 34.3 ± 13.6 | 32.1 ± 11.7 | 37.2 ± 15.0 | 0.000 |
| LDL-C, mg/dL | 144.2 ± 80.3 | 138.1 ± 74.9 | 152.1 ± 86.4 | 0.155 |
| Smoking, n (%) | 0.214 | |||
| Yes | 63 (20.3) | 48 (22.1) | 15 (15.9) | – |
| No | 248 (79.7) | 169 (77.9) | 79 (84.1) | – |
Values are presented as mean ± SD. p-values are obtained from the independent sample t-test.
BMI, body mass index; WC, waist circumference; HC, hip circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; XO, xanthine oxidase; SUA, serum uric acid; FBG, fasting blood glucose; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.